Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion.

Dimitrios NasioudisJinhee OhEmily M KoAshley F HaggertyLori CoryRobert L Giuntoli IiSarah H KimMark A MorganNawar A Latif

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2022)

In patients with high-intermediate risk FIGO stage I endometrioid endometrial carcinoma and lymphovascular invasion, addition of chemotherapy to radiation therapy was associated with a survival benefit for patients with grade 3 tumors receiving vaginal brachytherapy.

Keyphrases

radiation therapy
endometrial cancer
locally advanced
high dose
squamous cell carcinoma
lymph node metastasis
low dose
radiation induced
rectal cancer
breast cancer risk